Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT00998010 · COMPLETED
Trial details
- NCT number
- NCT00998010
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-03
- Primary completion
- 2016-03-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.